MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
QURE — uniQure N.V.
NasdaquniQure N.V.
$23.14
+0.08(+0.35%)
- O
- 22.96
- H
- 23.30
- L
- 22.62
- V
- 1.75M
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About QURE
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 5, 2014
Employees221
Stock ExchangeNasdaq
Ticker SymbolQURE
Websitehttps://www.uniqure.com
Key Financial Statistics
| Market Cap | $1.63B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $8.73 - $71.50 |
| 52-Week Avg Volume | 2.66M |
| VWAP | $22.97 |
| Transactions | 18,343 |
| Total Recorded Bars | 3,187 days |